Importantly, research into T cells in rheumatoid arthritis has led to novel treatments to treat this disease such as the TNF-α inhibitor, etanercept [14] and IL-6 antagonist tocilizumab [15] which inhibit or neutralize TNF-α and IL-6 respectively. The gene discussed is TNF; the disease is rheumatoid arthritis.